Weight Change in Midlife and Risk of Mortality From Dementia up to 35 Years Later.

J Gerontol A Biol Sci Med Sci

Department of Community Medicine, Institute of Health and Society, University of Oslo, Norway.

Published: June 2017

Background: The relationship between body mass index (BMI) and dementia is complex and controversial. This study investigates the association of weight change during midlife and later dementia-related mortality.

Methods: Two BMI measurements (average of 9.0 years apart) were available for 43,721 participants in the Norwegian Counties Study (NCS), with mean age 42 years at first BMI measurement and 51 at the final measurement. NCS was linked with the Cause of Death Registry until year 2015 (mean follow-up time 25.9 years). Cox regression with a conditional growth model was used.

Results: Our study comprised 1,205 dementia-related deaths. Weight loss was associated with increased dementia-related mortality, irrespectively of baseline BMI and confounders; those with 10% or more loss had hazard ratio (HR) = 1.52 (95% confidence interval [CI]: 1.09, 2.12) compared to those being stable (0%-2.5% BMI gain), and those with 5%-10% loss had HR = 1.38 (95% CI: 1.08, 1.76). Gaining weigh was associated with reduced dementia-related mortality. Associations with BMI change did not vary by baseline BMI.

Conclusions: Weight loss during midlife was associated with increased dementia-related mortality risk more than 3 decades later, while weight gain was associated with reduced risk. These associations held both for low and high baseline BMI. Weight loss was an independent risk factor for dementia-related mortality and more strongly related with dementia-related mortality than stable BMI (stable high or low). Overweight and obesity were associated with an increased risk for nondementia-related mortality, which was far more common than dementia-related mortality.

Download full-text PDF

Source
http://dx.doi.org/10.1093/gerona/glw157DOI Listing

Publication Analysis

Top Keywords

dementia-related mortality
24
weight loss
12
associated increased
12
weight change
8
change midlife
8
mortality
8
bmi
8
dementia-related
8
increased dementia-related
8
baseline bmi
8

Similar Publications

Social patterning of cognitive impairment in Colombia: evidence from the SABE 2015 study.

BMC Geriatr

December 2024

Universidad de los Andes, Escuela de Gobierno Alberto Lleras Camargo, Carrera 1° N° 19-27. Bloque AU, Piso 2, Bogotá, 111711, Colombia.

Introduction: Dementia, an increasingly critical public health concern in low and middle-income countries, is associated with lower socioeconomic status, early cognitive impairment, and elevated dementia-related mortality risk. This study seeks to estimate the prevalence of cognitive impairment, investigate its links with social indicators, and visualize social gradients across different regions in Colombia.

Methods: Secondary data analysis from the SABE 2015 survey, multinomial regression analyses, and equiplot graphs.

View Article and Find Full Text PDF

Objective: The risk of Alzheimer's disease (AD) and other dementias increases with greater global exposure to metabolic risks, making this a crucial public health issue. This study aimed to report the metabolism-attributable global burden of AD and other dementias from 1990 to 2021.

Methods: The Global Burden of Disease Study (GBD) 2021 collected data on the number of deaths and disability-adjusted life-years (DALYs) related to AD and other dementias caused by metabolic risks, including high fasting plasma glucose (FPG) and high body mass index (BMI).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates Alzheimer's disease-related psychosis (ADP) in older adults, focusing on demographic and clinical differences between those treated with antipsychotics and those who are not.
  • Researchers analyzed data from over 145,000 ADP patients, comparing health outcomes related to falls, fractures, seizures, and mortality between the two groups.
  • Findings reveal that antipsychotic users had more baseline health issues and higher rates of falls, fractures, and mortality compared to nonusers, indicating a significant impact of antipsychotic treatment on health outcomes in ADP patients.
View Article and Find Full Text PDF

The relationship between key energy metabolites and brain health is not well understood. We investigated the association between circulating ketone bodies, pyruvate, and citrate with cognitive decline, structural brain characteristics, and risk of dementia. We measured ketone bodies (acetoacetate, β-hydroxybutyrate, and acetone), pyruvate, and citrate species using NMR in plasma samples from 1,850 older adults in the Cardiovascular Health Study collected in 1989-90 or 1992-93.

View Article and Find Full Text PDF
Article Synopsis
  • Dementia is a growing global healthcare challenge, impacting memory and social abilities while necessitating targeted interventions based on mortality trends and high-risk populations.
  • An analysis of CDC WONDER data from 1999-2020 revealed over 4 million dementia-related deaths in the U.S., predominantly from Alzheimer's disease and unspecified dementia, with notable differences in mortality rates based on demographics and geography.
  • The age-adjusted mortality rates showed a steep increase from 1999 to 2010, followed by a slower rise until 2020, with females and non-Hispanic whites experiencing the highest rates, while the lowest were found among non-Hispanic Asians or Pacific Islanders.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!